Effects of wearing supportive underwear versus pelvic floor muscle training or no treatment in women with symptoms of stress urinary incontinence: an assessor-blinded randomized control trial
Effects of wearing supportive underwear versus pelvic floor muscle training or no treatment in women with symptoms of stress urinary incontinence: an assessor-blinded randomized control trial
复制标题
DOI：
10.1007/s00192-018-03855-z
复制
发表时间：
2019-07-01
影响因子：
1.8
通讯作者：
Morikawa, Shigehiro
中科院分区：
文献类型：
--
作者：
Okayama, Hisayo;Ninomiya, Sanae;Morikawa, Shigehiro
介绍和假设在我们以前的单臂试点研究中，我们报告说，现成的支持性内衣（塑形器）是有效的提高膀胱颈和减少尿失禁（UI）的症状。本研究的目的是确定穿着塑形器的效果与在家中使用带有音乐的训练光盘或不进行治疗的骨盆底肌肉训练（PFMT）相比，在一项评估者盲法随机对照试验中，对减少UI症状的影响。MethodsParticipants aged 30- 59 years with symptoms of stress urinary incontinence随机分为三组：塑形组、PFMT组和未治疗组。UI发作/周和日本版的国际咨询Inflammatory问卷短格式进行了比较基线和第6或第12周的干预period.Results89名妇女谁完成了12周的干预期进行了分析。在12周的干预期后，成形器组、PFMT组和未治疗组的UI症状改善率（UI发作/周较基线至少减少50%的病例数比率）分别为73.3%（22/30名女性）、74.2%（23/31名女性）和25.0%（7/28名女性）。成形剂组和PFMT组UI症状改善率明显高于未治疗组（均P
Introduction and hypothesisIn our previous single-arm pilot study, we reported that ready-made supportive underwear (shaper) was effective in elevating the bladder neck and reducing urinary incontinence (UI) symptoms. The aim of this study was to determine the effects of wearing a shaper compared with pelvic floor muscle training (PFMT) at home using a training compact disc with music, or no treatment, in an assessor-blinded randomized control trial, on reducing UI symptoms.MethodsParticipants aged 30-59years with symptoms of stress urinary incontinence were randomly assigned to three groups: the shaper group, PFMT group, and no treatment group. The UI episodes/week and the Japanese version of the International Consultation on Incontinence Questionnaire Short-Form were compared between the baseline and the 6th or 12th week of the intervention period.ResultsEighty-nine women who completed the 12-week intervention period were analyzed. After the 12-week intervention period, the improvement rate in UI symptoms (ratio of the case number in which the UI episodes/week decreased at least 50% from the baseline) was 73.3% (22/30 women) in the shaper group, 74.2% (23/31 women) in the PFMT group, and 25.0% (7/28 women) in the no treatment group. The improvement rate in UI symptoms in the shaper and PFMT groups was significantly higher than that in the no treatment group (both P